Pharmaceutical Product Registration in Nigeria: The NAFDAC Process Explained

For locally manufactured products, the applicant is the Nigerian manufacturer. The manufacturing facility must satisfy NAFDAC's Good Manufacturing Practice (GMP) requirements and will be inspected as part of the registration process. For pharmaceutical manufacturing, the company must also have the appropriate PCN premises licensing and a superintendent pharmacist.

For imported products, a foreign manufacturer cannot apply directly. The application must come through a local applicant — a company incorporated in Nigeria (with CAC registration) that holds a power of attorney or contract manufacturing agreement from the product's manufacturer authorising it to register and market the product in Nigeria. For drugs, that local representative must itself be a licensed pharmaceutical company with a superintendent pharmacist.

This structure matters commercially: the power of attorney effectively determines who controls the brand's registration in Nigeria, so both sides should take legal advice before signing. NAFDAC generally will not register the same product for two different applicants at the same time.

NAFDAC product registration applications are made electronically through NAPAMS — the NAFDAC Automated Product Administration and Monitoring System. The applicant creates a company account, selects the product category (human drug, herbal medicine, food, cosmetic, medical device, and so on), completes the application form, uploads the dossier documents, and pays the prescribed fees online.

Everything after submission — queries from NAFDAC reviewers, scheduling of inspections, status updates, and ultimately the approval — is tracked against that application in the portal. Keep the account credentials and the registered email under the company's control rather than an agent's personal email; losing access to the account that holds your registrations is a common and painful mistake.

Note that NAPAMS is an industry-facing system for companies registering products. Consumers checking whether a product is registered do not need any portal account — the public NAFDAC Greenbook and tools like the Ogbogwu NAFDAC Checker are free to search.

The exact checklist varies by product category, but for pharmaceutical products the core requirements are consistent. The applicant needs evidence of company incorporation with the Corporate Affairs Commission (CAC); evidence of trademark registration or filing for the brand name; and, for imported products, a notarised power of attorney from the manufacturer plus a Certificate of Pharmaceutical Product (COPP) issued by the regulatory authority in the country of manufacture.

The technical heart of the application is the product dossier, prepared in the Common Technical Document (CTD) format: administrative information, product information and labelling, quality documentation (composition, specifications, manufacturing process, stability data), and safety and efficacy data appropriate to the product type. Generic products lean on established data; new chemical entities need substantially more.

The applicant must also submit product samples for NAFDAC laboratory analysis, along with the proposed labels and packaging artwork. Labels must meet NAFDAC labelling regulations — including the product name, active ingredients and strengths, batch details, manufacturer's name and address, and the space where the NAFDAC number will be printed once issued.

Fees are prescribed by NAFDAC's current tariff and differ by product category and by whether the product is locally manufactured or imported (imported products also attract GMP inspection costs for the overseas facility). Check the current tariff on nafdac.gov.ng rather than relying on figures quoted in articles — they change.

First, the applicant opens a NAPAMS account and submits the application with the dossier and fees. NAFDAC screens the submission for completeness, then the dossier goes into technical review, where assessors can (and usually do) raise queries the applicant must answer through the portal.

Second, the manufacturing facility is inspected for GMP compliance. For local products this is an inspection of the Nigerian factory; for imported products NAFDAC inspects the overseas manufacturing site (or relies on a still-valid previous GMP inspection of that site). Facility inspection is frequently the longest single step for imported products, since inspections are scheduled in batches by country.

Third, the submitted samples are analysed in NAFDAC's laboratories to confirm the product meets its specifications. Finally, applications that pass review, inspection, and analysis go to NAFDAC's approval meeting. Approved products are issued a Certificate of Registration with the NAFDAC registration number, and the product enters the Greenbook — Nigeria's public register of approved products.

NAFDAC's published service timeline for a straightforward, complete drug application is on the order of 90 to 120 working days. In practice, applications with dossier gaps, slow query responses, or pending overseas inspections can take considerably longer — a year or more is not unusual for imported products. The single biggest thing an applicant controls is submitting a complete dossier and answering queries fast.

Most delays are self-inflicted. Incomplete dossiers — missing stability data, unsigned documents, artwork that does not match the formulation — send applications back to the queue. Slow responses to reviewer queries add months. Brand names that infringe an existing trademark, or that are already registered by another applicant, stop an application outright.

For imported products, the classic blockers are an expired or improperly notarised power of attorney, a COPP that does not match the dossier details, and GMP inspections that have not been scheduled or paid for. Products whose laboratory samples fail analysis are rejected — and a failed analysis also puts the manufacturer on NAFDAC's radar.

Applicants should also be wary of unofficial 'fast-track' promises from third-party agents. NAFDAC has legitimate expedited pathways for certain categories (such as life-saving medicines), but anyone offering to buy speed outside the published process is a compliance risk to your business.

Registration is not the finish line. The NAFDAC number must appear on every pack, and the product as sold must continue to match what was approved — changes to formulation, manufacturing site, pack size, or labelling require a variation application, not a quiet update. NAFDAC runs post-market surveillance, sampling products from the market and acting against those that fail.

For high-risk categories such as antimalarials and some antibiotics, NAFDAC also requires the Mobile Authentication Service (MAS) scratch panel on packs, letting consumers verify a pack by SMS before use.

Registration certificates are typically valid for five years. Renewal applications should be filed well before expiry — selling a product whose registration has lapsed is treated the same as selling an unregistered product. You can confirm any product's current registration status in the NAFDAC Greenbook or with the Ogbogwu NAFDAC Checker.